On March 20, 2026, 60 Degrees Pharmaceuticals, Inc. filed a Form 8-K to correct an error in the calculation of shares beneficially owned by an affiliate, as previously disclosed in their prospectus supplement dated March 13, 2026. The company initially reported that the affiliate owned 21,490 shares; however, the correct figure is 23,367 shares. This discrepancy arose from an incorrect total share amount reported in a Form 4 filed on September 15, 2025, which was carried forward into subsequent filings, including another Form 4 on December 16, 2025, and ultimately into the Prospectus Supplement. The corrected total number of shares beneficially owned by the affiliate is now stated as 16,781 shares, rather than the previously reported 15,905 shares, after accounting for a 1-for-4 reverse stock split. The company emphasized that aside from this correction, no other information in the Prospectus Supplement is affected. This filing serves to ensure accurate disclosure and compliance with SEC regulations, reflecting the company's commitment to transparency and governance.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.